Skip to content

evaluation of efficacy of synbiotics in children with eosinophilic esophagitis

evaluation of efficacy of synbiotics in resolution of symptoms , pathologic and endoscopic findings in children with eosinophilic esophagitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171230038142N14
Enrollment
40
Registered
2020-03-11
Start date
2019-10-23
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eosinophilic esophagitis. Eosinophilic esophagitis

Interventions

Intervention 1: Intervention group: They will be treated for at least 8 weeks with omeprazole (Iranian from Abidi Pharmacy) at a dose of 1 mg / kg, daily, also under appropriate diet (given nutritiona

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 15 Years

Inclusion criteria

Inclusion criteria: Patient parental consent to participate in the study Eosinophilic esophagitis is diagnosed and confirmed by endoscopy Patients age 6 months to 15 years

Exclusion criteria

Exclusion criteria: Use of other medicines that can improve the disease.

Design outcomes

Primary

MeasureTime frame
Clinical symptoms. Timepoint: Before and eight weeks after intervention. Method of measurement: Examination by a pediatrician.;Pathologic findings. Timepoint: Before and eight weeks after intervention. Method of measurement: Gastric biopsy and eosinophil count by microscope.;Endoscopic findings. Timepoint: Before and eight weeks after intervention. Method of measurement: Endoscopy in hospital by pediatric gastroenterologist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloufar Zamani

Esfahan University of Medical Sciences

gebrahimi676@gmail.com+98 31 3668 8597

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026